Healthcare - Biotechnology - NASDAQ - US
$ 4.19
-2.1 %
$ 249 M
Market Cap
-3.3
P/E
BALANCE SHEET
174 M
ASSETS
48 M
LIABILITIES
126 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Pyxis Oncology, Inc.
| Current Assets | 125 M |
| Cash & Short-Term Investments | 119 M |
| Receivables | 21 K |
| Other Current Assets | 5.28 M |
| Non-Current Assets | 49.1 M |
| Long-Term Investments | 0 |
| PP&E | 24.8 M |
| Other Non-Current Assets | 24.3 M |
| Current Liabilities | 25.8 M |
| Accounts Payable | 3.9 M |
| Short-Term Debt | 2.46 M |
| Other Current Liabilities | 19.4 M |
| Non-Current Liabilities | 22.3 M |
| Long-Term Debt | 20.1 M |
| Other Non-Current Liabilities | 2.16 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 9.7 | 179.3 | 274.7 | 8.1 | 19.7 |
| Short Term Investments | 109.6 | 0 | 0 | 0 | 0 |
| Receivables | 21 K | 0.6 | 0 | 0 | 0 |
| Inventory | 0 | 0.9 | 0 | 0 | 0 |
| Other Current Assets | 5.3 | 6.7 | 3.9 | 23 K | 11 K |
| Total Current Assets | 124.6 | 186.6 | 278.7 | 8.1 | 19.7 |
| PP&E | 24.8 | 24.8 | 1.2 | 1.9 | 76 K |
| Intangible Assets | 24.3 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 0 | 0.1 | 0.1 | 30 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 173.7 | 211.4 | 280.0 | 10.2 | 19.8 |
| LIABILITIES | |||||
| Accounts Payable | 3.9 | 7.1 | 12.0 | 1.1 | 0.5 |
| Short Term Debt | 2.5 | 0 | 0.3 | 0.6 | 9 K |
| Other Current Liabilities | 11.7 | 24.5 | 6.4 | 1.9 | 0.1 |
| Total Current Liabilities | 25.8 | 31.6 | 18.7 | 3.7 | 0.7 |
| Long Term Debt | 20.1 | 18.9 | 0 | 0.2 | 6 K |
| Deferred Tax Income | 2.2 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 21.9 | 21.9 |
| Total Liabilities | 48.0 | 50.6 | 18.7 | 25.8 | 22.7 |
| EQUITY | |||||
| Common Stock | 45 K | 34 K | 32 K | 1 K | 1 K |
| Retained Earnings | (286.2) | (212.4) | (91.7) | (15.7) | (2.9) |
| Other Accumulative Comprehensive Income/Loss | 63 K | 0 | (280.0) | (21.9) | (21.9) |
| Total Equity | 125.7 | 160.8 | 261.3 | (15.6) | (2.9) |
| Total Liabilities and Equity | 173.7 | 211.4 | 280.0 | 10.2 | 19.8 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 39.9 | 33.0 | 32.2 | 34.3 | 34.3 |